No­vo Nordisk to boost oral GLP-1 man­u­fac­tur­ing via $92.5M buy for Alk­er­mes’ Ire­land fa­cil­i­ty

No­vo Nordisk will buy Alk­er­mes’ tablet­ing fa­cil­i­ty in Athlone, Ire­land, for $92.5 mil­lion in cash to man­u­fac­ture one of its block­buster GLP-1 drugs — Ry­bel­sus …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER